Cargando…

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis

BACKGROUND: The World Health Organization (WHO) has set ambitious targets for the elimination of onchocerciasis by 2020–2025 through mass ivermectin treatment. Two different mathematical models have assessed the feasibility of reaching this goal for different settings and treatment scenarios, namely...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolk, Wilma A., Walker, Martin, Coffeng, Luc E., Basáñez, María-Gloria, de Vlas, Sake J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618738/
https://www.ncbi.nlm.nih.gov/pubmed/26489937
http://dx.doi.org/10.1186/s13071-015-1159-9
_version_ 1782396968426799104
author Stolk, Wilma A.
Walker, Martin
Coffeng, Luc E.
Basáñez, María-Gloria
de Vlas, Sake J.
author_facet Stolk, Wilma A.
Walker, Martin
Coffeng, Luc E.
Basáñez, María-Gloria
de Vlas, Sake J.
author_sort Stolk, Wilma A.
collection PubMed
description BACKGROUND: The World Health Organization (WHO) has set ambitious targets for the elimination of onchocerciasis by 2020–2025 through mass ivermectin treatment. Two different mathematical models have assessed the feasibility of reaching this goal for different settings and treatment scenarios, namely the individual-based microsimulation model ONCHOSIM and the population-based deterministic model EPIONCHO. In this study, we harmonize some crucial assumptions and compare model predictions on common outputs. METHODS: Using a range of initial endemicity levels and treatment scenarios, we compared the models with respect to the following outcomes: 1) model-predicted trends in microfilarial (mf) prevalence and mean mf intensity during 25 years of (annual or biannual) mass ivermectin treatment; 2) treatment duration needed to bring mf prevalence below a provisional operational threshold for treatment interruption (pOTTIS, i.e. 1.4 %), and 3) treatment duration needed to drive the parasite population to local elimination, even in the absence of further interventions. Local elimination was judged by stochastic fade-out in ONCHOSIM and by reaching transmission breakpoints in EPIONCHO. RESULTS: ONCHOSIM and EPIONCHO both predicted that in mesoendemic areas the pOTTIS can be reached with annual treatment, but that this strategy may be insufficient in very highly hyperendemic areas or would require prolonged continuation of treatment. For the lower endemicity levels explored, ONCHOSIM predicted that the time needed to reach the pOTTIS is longer than that needed to drive the parasite population to elimination, whereas for the higher endemicity levels the opposite was true. In EPIONCHO, the pOTTIS was reached consistently sooner than the breakpoint. CONCLUSIONS: The operational thresholds proposed by APOC may have to be adjusted to adequately reflect differences in pre-control endemicities. Further comparative modelling work will be conducted to better understand the main causes of differences in model-predicted trends. This is a pre-requisite for guiding elimination programmes in Africa and refining operational criteria for stopping mass treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-015-1159-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4618738
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46187382015-10-25 Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis Stolk, Wilma A. Walker, Martin Coffeng, Luc E. Basáñez, María-Gloria de Vlas, Sake J. Parasit Vectors Research BACKGROUND: The World Health Organization (WHO) has set ambitious targets for the elimination of onchocerciasis by 2020–2025 through mass ivermectin treatment. Two different mathematical models have assessed the feasibility of reaching this goal for different settings and treatment scenarios, namely the individual-based microsimulation model ONCHOSIM and the population-based deterministic model EPIONCHO. In this study, we harmonize some crucial assumptions and compare model predictions on common outputs. METHODS: Using a range of initial endemicity levels and treatment scenarios, we compared the models with respect to the following outcomes: 1) model-predicted trends in microfilarial (mf) prevalence and mean mf intensity during 25 years of (annual or biannual) mass ivermectin treatment; 2) treatment duration needed to bring mf prevalence below a provisional operational threshold for treatment interruption (pOTTIS, i.e. 1.4 %), and 3) treatment duration needed to drive the parasite population to local elimination, even in the absence of further interventions. Local elimination was judged by stochastic fade-out in ONCHOSIM and by reaching transmission breakpoints in EPIONCHO. RESULTS: ONCHOSIM and EPIONCHO both predicted that in mesoendemic areas the pOTTIS can be reached with annual treatment, but that this strategy may be insufficient in very highly hyperendemic areas or would require prolonged continuation of treatment. For the lower endemicity levels explored, ONCHOSIM predicted that the time needed to reach the pOTTIS is longer than that needed to drive the parasite population to elimination, whereas for the higher endemicity levels the opposite was true. In EPIONCHO, the pOTTIS was reached consistently sooner than the breakpoint. CONCLUSIONS: The operational thresholds proposed by APOC may have to be adjusted to adequately reflect differences in pre-control endemicities. Further comparative modelling work will be conducted to better understand the main causes of differences in model-predicted trends. This is a pre-requisite for guiding elimination programmes in Africa and refining operational criteria for stopping mass treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-015-1159-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-22 /pmc/articles/PMC4618738/ /pubmed/26489937 http://dx.doi.org/10.1186/s13071-015-1159-9 Text en © Stolk et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Stolk, Wilma A.
Walker, Martin
Coffeng, Luc E.
Basáñez, María-Gloria
de Vlas, Sake J.
Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
title Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
title_full Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
title_fullStr Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
title_full_unstemmed Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
title_short Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
title_sort required duration of mass ivermectin treatment for onchocerciasis elimination in africa: a comparative modelling analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618738/
https://www.ncbi.nlm.nih.gov/pubmed/26489937
http://dx.doi.org/10.1186/s13071-015-1159-9
work_keys_str_mv AT stolkwilmaa requireddurationofmassivermectintreatmentforonchocerciasiseliminationinafricaacomparativemodellinganalysis
AT walkermartin requireddurationofmassivermectintreatmentforonchocerciasiseliminationinafricaacomparativemodellinganalysis
AT coffengluce requireddurationofmassivermectintreatmentforonchocerciasiseliminationinafricaacomparativemodellinganalysis
AT basanezmariagloria requireddurationofmassivermectintreatmentforonchocerciasiseliminationinafricaacomparativemodellinganalysis
AT devlassakej requireddurationofmassivermectintreatmentforonchocerciasiseliminationinafricaacomparativemodellinganalysis